4-Imidazolidinone, 1-[[1-(3-chloro-4-fluorophenyl)-5-(3-chloro-5-fluorophenyl)-1H-pyrazol-3-yl]carbonyl]- → HCID 58277439, 화합물
반응식
[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2[N:13]([C:14]3[CH:19]=[CH:18][CH:17]=[C:16]([Cl:20])[CH:15]=3)[N:12]=[C:11]([C:21](O)=[O:22])[CH:10]=2)[CH:5]=[CH:6][C:7]=1[F:8].ClC1C=C(N2C(C3C=C(F)C=C(Cl)C=3)=CC(C([N:47]3[CH2:51][C:50](=[O:52])[NH:49][CH2:48]3)=O)=N2)C=CC=1F>>[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2[N:13]([C:14]3[CH:19]=[CH:18][CH:17]=[C:16]([Cl:20])[CH:15]=3)[N:12]=[C:11]([C:21]([N:47]3[CH2:51][C:50](=[O:52])[NH:49][CH2:48]3)=[O:22])[CH:10]=2)[CH:5]=[CH:6][C:7]=1[F:8]참가 물질
3
실험 절차
The preparation of the title compound takes place starting from the compound of Example 79A in analogy to the synthesis of the compound of Example 1. 52 mg (87% of theory) of the title compound are obtained.
출처 및 근거
- ORD 기록
- ord-926cbca07b444c33aa3ee16ed41ac5e1
- 출처 데이터셋
- uspto-grants-2013_03
- 특허 번호
- US08399682B2
반응 노트
불러오는 중…